Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive Neuroendocrine Tumors

Martijn van Essen, Dik J. Kwekkeboom, Wouter W. de Herder, Lisa Bodei, Boen L R Kam, Marion de Jong, Roelf Valkema, Eric P. Krenning

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish
Title of host publicationMonoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer
PublisherJohn Wiley and Sons
Number of pages18
ISBN (Print)9780470243725
Publication statusPublished - Jul 15 2010


  • Improving PRRT and future directions
  • Peptide Receptor Radionuclide Therapy (PRRT) in patients - with somatostatin receptor-positive neuroendocrine tumors
  • PRRT with radiolabeled somatostatin analogues - treatment modality for patients with inoperable or metastasized endocrine GEP tumors

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this